Table 3.
Symptom at time of onset of COVID 19 among study participants.
Symptom | KSK (n = 51) n (%) | Standard care(n = 49) n (%) | P value |
---|---|---|---|
Any Symptom | 39 (76.5%) | 44 (89.8%) | 0.177 |
Fever | 30 (58.8%) | 27 (55.1%) | 0.7 |
Sore throat | 35 (68.6%) | 36 (73.4%) | 0.59 |
Runny nose | 25 (49%) | 26 (53%) | 0.68 |
Cough | 22 (43.1%) | 28 (57.1%) | 0.16 |
Shortness of breath | 6 (11.8%) | 15 (30.6%) | 0.02∗ |
Other | |||
Myalgia | 23 (43.09%) | 14 (28.5%) | 0.15 |
Headache | 2 (3.9%) | 0 | Not calculated |
Diarhoea | 3 (5.8%) | 1 (2.04%) | Not calculated |
Weakness | 5 (9.8%) | 2 (8.1%) | Not calculated |
No smell | 4 (7.8%) | 9 (18.4%) | 0.14 |
∗ significant.